Abstract: An electronic apparatus that (a) receives first data from a server, the first data including a first section in which first content data of requested content is included and a second section in which advertisement content data is insertable, but is not inserted, (b) controls the display to output a portion of content corresponding to the first content data, (c) receives second data while the portion of the content is being output by the display, the second data including a first section in which second content data of the requested content is included and a second section into which advertisement content data is inserted, and (d) controls the display to output advertisement content corresponding to the advertisement content data inserted into the second section of the received second data, based on a current playback point of the content corresponding to the first content data and the second content data.

Abstract: An electronic apparatus includes a communicator connected to a Local Area Network (LAN), an inputter, a memory storing at least one computer executable instruction, and a processor. The processor outputs a content of a first channel received through the communicator, receives information associated with contents of a plurality of channels through the communicator and stores the information in the memory while the content of the first channel is being output, and based on an instruction change the first channel to a second channel while the content of the first channel is output, acquires information associated with the content of the second channel among the stored information associated with the contents of the plurality of channels from the memory, and decodes the content of the second channel received through the communicator by using the acquired information on the content of the second channel and outputs the decoded content.

Abstract: An electronic apparatus includes a communicator connected to a Local Area Network (LAN), an inputter, a memory storing at least one computer executable instruction, and a processor. The processor outputs a content of a first channel received through the communicator, receives information associated with contents of a plurality of channels through the communicator and stores the information in the memory while the content of the first channel is being output, and based on an instruction change the first channel to a second channel while the content of the first channel is output, acquires information associated with the content of the second channel among the stored information associated with the contents of the plurality of channels from the memory, and decodes the content of the second channel received through the communicator by using the acquired information on the content of the second channel and outputs the decoded content.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Abstract: 2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-? or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-? or PDE4.

Abstract: This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Abstract: 2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-? or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-? or PDE4.